Role of the PD-1 and PD-L1 axis in COVID-19.
COVID-19
PD-1
PD-L1
SARS-CoV-2
adaptive immune cells
immune checkpoint molecules
innate immune cells
Journal
Future microbiology
ISSN: 1746-0921
Titre abrégé: Future Microbiol
Pays: England
ID NLM: 101278120
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
pubmed:
29
7
2022
medline:
17
8
2022
entrez:
28
7
2022
Statut:
ppublish
Résumé
Tweetable abstract Severe COVID-19 patients display dysregulated expression of checkpoint molecules PD-1 and its ligand PD-L1, suggesting that these checkpoint molecules could be considered as prognostic markers and therapeutic targets in severe cases of COVID-19.
Identifiants
pubmed: 35899493
doi: 10.2217/fmb-2022-0103
pmc: PMC9332906
doi:
Substances chimiques
B7-H1 Antigen
0
Programmed Cell Death 1 Receptor
0
Types de publication
Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM